Balanced news tone
News Sentiment
504A sentiment intelligence
Innovacell Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
62/100 classification confidence.
directly relevant articles
high-authority source matches
-9.4% over one week, -3.7% over four weeks, trend inactive, and below fair value.
Price to earnings forward of Innovacell Inc. – TSE:504A
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Price to earnings forward of Innovacell Inc. – TSE:504A
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 12 Jul 2026 19:36
- Source
- TradingView
Innovacell Wins FDA Green Light to Globalize Phase III Trial for Fecal Incontinence Cell Therapy
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 07:24
- Source
- TipRanks
Innovacell Inc Announces Completion of FDA IND Review And Approval To Include U.S. Sites And Patients In ICEF15 Multi-Regional Phase III Fidelia Trial
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 02 Jul 2026 07:00
- Source
- marketscreener.com
Innovacell’s $91M Tokyo IPO to fund incontinence cell therapies
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Feb 2026 08:00
- Source
- BioWorld News